NCT04604782: A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 54 planned
- Started
- 20 May 2021
- Primary completion
- Dec 2026
- Arms
- adolescents aged 12 to <18 years, children aged 2 to <12 years, infants aged 1 to <24 months and who weigh at least 3 kg
- Results
- None posted
- 27 Oct 2020: Trial registered
- 20 May 2021: Trial started